AngioDynamics, Inc.
ANGO
$9.48
-$0.12-1.25%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 283.32M | 286.50M | 292.73M | 303.91M | 324.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 283.32M | 286.50M | 292.73M | 303.91M | 324.01M |
| Cost of Revenue | 126.42M | 132.59M | 138.46M | 146.32M | 161.47M |
| Gross Profit | 156.90M | 153.91M | 154.26M | 157.60M | 162.54M |
| SG&A Expenses | 143.91M | 143.86M | 142.58M | 144.18M | 145.67M |
| Depreciation & Amortization | 10.30M | 10.99M | 11.99M | 13.05M | 14.88M |
| Other Operating Expenses | 5.76M | 5.76M | 5.76M | 5.76M | -- |
| Total Operating Expenses | 312.41M | 320.54M | 328.41M | 340.62M | 354.48M |
| Operating Income | -29.09M | -34.04M | -35.69M | -36.70M | -30.47M |
| Income Before Tax | -42.06M | -237.39M | -239.16M | -191.64M | -199.36M |
| Income Tax Expenses | -671.00K | -12.67M | 3.87M | -7.29M | -7.00M |
| Earnings from Continuing Operations | -41.39 | -224.72 | -243.03 | -184.35 | -192.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.39M | -224.72M | -243.03M | -184.35M | -192.37M |
| EBIT | -29.09M | -34.04M | -35.69M | -36.70M | -30.47M |
| EBITDA | -4.71M | -8.46M | -10.28M | -11.39M | -2.02M |
| EPS Basic | -1.02 | -5.58 | -6.04 | -4.57 | -4.78 |
| Normalized Basic EPS | -0.35 | -0.51 | -0.53 | -0.56 | -0.48 |
| EPS Diluted | -1.02 | -5.58 | -6.04 | -4.58 | -4.78 |
| Normalized Diluted EPS | -0.35 | -0.51 | -0.53 | -0.56 | -0.48 |
| Average Basic Shares Outstanding | 162.86M | 162.24M | 161.53M | 160.72M | 159.90M |
| Average Diluted Shares Outstanding | 162.86M | 162.24M | 161.53M | 160.85M | 160.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |